Viatris' Q4 2023 earnings missed estimates with 61 cents per share and $3.8 billion in revenues, down 1% year-over-year. Despite a 14% sales increase in Emerging Markets, overall performance was mixed. The company paid down $500 million in debt and entered a R&D collaboration with Idorsia Ltd. for two phase III assets. 2024 revenue is projected between $15.25-$15.75 billion, with EPS expected at $2.70-$2.85.